NCT01396421 - Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia | Biotech Hunter

Enrollment

636

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Acute Schizophrenia

Interventions

DRUG

OPC-34712 [Brexpiprazole] High Dose

Higher dose, tablet, once daily, for six weeks

DRUG

Experimental: OPC-34712 [Brexpiprazole] Middle Dose

Middle dose, tablet, once daily, for six weeks

DRUG

Experimental: OPC-34712 [Brexpiprazole] Low Dose

Lower dose, tablet, once daily, for six weeks

DRUG

Placebo

Placebo, once daily, for six weeks

Trial Locations (60)

11000

Belgrade

11423

Fresh Meadows

11432

Jamaica

14000

Chernihiv

21000

Novi Sad

21005

Vinnytsia

29405

Charleston

29407

Charleston

32806

Orlando

33166

Miami Springs

34000

Kragujevac

34208

Bradenton

45417

Dayton

49005

Dnipropetrovsk

49115

Dnipropetrovsk

72205

Little Rock

73488

Kherson, Vil. Stepanivka

78754

Austin

79021

Lviv

91206

Glendale

92056

Oceanside

92102

San Diego

92123

San Diego

92845

Garden Grove

94612

Oakland

95006

Simferopol

98033

Kirkland

110069

Piteşti

130086

Târgovişte

310022

Arad

400012

Cluj-Napoca

620165

Focşani

L7R 4E2

Burlington

N7L 1B7

Chatham

N7M 5L9

Chatham

251-8530

Fujisawa-shi

904-1201

Kunigami-gun

590-0018

Sakai-shi

156-0057

Setagaya-ku

861-8002

Kumamoto

LV-5417

Daugavpils

LV-3008

Jelgava

LV-3401

Liepāja

LV-1005

Riga

LV-4730

Strenči

16-070

Choroszcz

80-282

Gdansk

80-952

Gdansk

91-229

Lodz

010825

Bucharest

030442

Bucharest

041914

Bucharest

400-711

Incheon

405-760

Incheon

136-705

Seoul

137-710

Seoul

143-711

Seoul

08631

Hlevakha

02660

Kyiv

04080

Kyiv

All Listed Sponsors

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY